The renaissance of insulin pump treatment in childhood type 1 diabetes

Reviews in Endocrine and Metabolic Disorders

Volumn 7, Issue 3, 2006, Pages 205-213

  Tamborlane, William V ^a   Swan, Karena ^a   Sikes, Kristin A ^a   Steffen, Amy T ^a   Weinzimer, Stuart A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Continuous subcutaneous insulin infusion; Hypoglycemia; Pump therapy

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; LONG ACTING INSULIN; RAPID ACTING INSULIN; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; AGE DISTRIBUTION; BLOOD GLUCOSE MONITORING; CHILD CARE; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; METERED DOSE INHALER; PATIENT SELECTION; QUALITY OF LIFE; REVIEW; SAFETY; SOCIAL PSYCHOLOGY; STRUCTURED INTERVIEW; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

CHILD; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFUSION PUMPS, IMPLANTABLE; INSULIN INFUSION SYSTEMS; PATIENT SELECTION; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 33846110248     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11154-006-9018-9     Document Type: Review

References (56)

1. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetics by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979;300 11:573-8.
2. Pickup JC, Keen H, Parsons JA, Alberti KG. Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia. Br Med J 1978;1 6107:204-7.
3. Lauritzen T, Pramming S, Deckert T, Binder C. Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia 1983;24 5:326-9.
4. Tamborlane WV, Sherwin RS, Genel M, Felig P. Outpatient management of juvenile-onset diabetics with a portable subcutaneous insulin infusion pump. Am J Med 1980;68:190-6.
5. DCCT Research Group. Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabetes Care 1995;18 11:1468-78.
6. Amiel SA, Tamborlane WV, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin dependent diabetes mellitus. N Engl J Med 1987;316:1376-83.
7. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counter-regulatory hormone release. Diabetes 1988;37:901-7.
8. Cryer PE. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious cycle. Diabetes 1992;41:255-60.
9. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial. N Engl J Med 1993;329 14:977-86.
10. The DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: the diabetes control and complications trial. J Pediatr 1994;125 2:177-88.
11. DCCT/EDIC Research Group. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the diabetes control and complications trial. J Pediatr 2001;139 6:804-12.
12. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion: a new way to achieve strict metabolic control, decrease severe hypoglycemia and enhance coping in adolescents with type I diabetes. Diabetes Care 1999;22 11:1779-84.
13. Ahern JA, Boland EA, Doane R, Ahern JJ, Rose P, Vincent M, et al. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower therapy HbA1c levels across all age groups. Pediatric Diabetes 2002;3 1:10-5.
14. Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001;107 2:351-6.
15. Plotnick LP, Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003;26 4:1142-46.
16. Sulli N, Shashaj B. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia. J Pediatr Endocrinol Metab 2003;16 3:393-9.
17. Willi SM, Planton J, Egede L, Schwarz S. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus. J Pediatr 2003;143 6:796-801.
18. Liberatore R Jr, Perlman K, Buccino J, Artiles-Sisk A, Daneman D. Continuous insulin infusion pump treatment in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2004;17 2:223-6.
19. Mack-Fogg JE, Orlowski CC, Jospe N. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective. Pediatric Diabetes 2005;6 1:17-21.
20. Weinzimer SA, Ahern JA, Doyle EA, Vincent MR, Dziura J, Steffen AT, et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004;114 6:1601-5.
21. Tubiana-Rufi N, deLonlay P, Bloch J, Czernichow P. Remission of severe hypoglycemic incidents in young diabetic children treated with subcutaneous infusion. Arch Pediatr 1996;3 10:969-76.
22. Litton J, Rice A, Friedman N, Oden J, Lee MM, Freemark M. Insulin pump therapy in toddlers and pre-school children with type 1 diabetes mellitus. J Pediatr 2002;141 4:490-5.
23. Shehadeh N, Battelino T, Galatzer A, Naveh T, Hadash A, de Vries L, et al. Insulin pump therapy for 1-6 year old children with type 1 diabetes. Isr Med Assoc J 2004;6 5:284-6.
24. Springer D, Dziura J, Tamborlane WV, Steffen AT, Ahern JH, Vincent M, Weinzimer SA. Optimal control of type 1 diabetes in youth receiving intensive treatment. J Pediatr 2006;149:227-32.
25. The DCCT Research Group. The absence of a glycemic threshold for the development of long-term complications the prospective of the diabetes control and complications trial. Diabetes 1996;45:1289-98.
26. de Beaufort CE, Houtzagers CM, Bruining GJ, Aarsen RS, den Boer NC, Grose WF, et al. Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial. Diabet Med 1989;6 9:766-71.
27. Weintrob N, Benzaquen H, Galatzar A, Shalitin S, Lazar L, Fayman G, et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003;112 3 Pt 1:559-64.
28. Heise T, Nosek L, Ronn BB, Endahl L, Heinemann L, Kapitza C, et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes 2004;53 6:1614-20.
29. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000;49 12:2142-8.
30. Kaplan W, Rodriguez LM, Smith OE, Haymond MW, Heptulla RA. Effects of mixing glargine and short-acting insulin analogs on glucose control. Diabetes Care 2004;27:2739-40.
31. Schober E, Schoenle E, Van Dyk J, Wernicke-Panten K, Pediatric Study Group of Insulin Glargine. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2002;15 4:369-76.
32. Murphy NP, Keane SM, Ong KK, Ford-Adams M, Edge JA, Acerini CL, et al. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens. Diabetes Care 2003;26 3:799-804.
33. White NH, Tamborlane W, Ususkin K. Less variability in blood glucose values with insulin glargine vs intermediate-acting insulin (NPH or Lente) in adolescents with T1DM. Diabetes 2006;55 Suppl 1:A138.
34. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004;27 7:1554-8.
35. Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gittelman SE. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005;28 1:15-9.
36. Di Meglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004;145 3:380-4.
37. Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005;28:1277-81.
38. Jeha GS. Karaviti LP. Anderson B. Smith EO. Donaldson S. McGirk TS. Haymond MW. Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther 2005;7:876-84.
39. The DirecNet Study Group. Impact of exercise on overnight glycemic control in children with type 1 diabetes. J Pediatr 2005;147:528-34.
40. The DirecNet Study Group. The effects of aerobic exercise on glucose and counter-regulatory hormone levels in children with type 1 diabetes. Diabetes Care 2006;29:20-5.
41. The Diabetes Research in Children Network (DirecNet) Study Group. Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care 2006;29:2200-4.
42. Burdick J, Chase HP, Slover RH, Knievel K, Scrimgeour L, Maniatis AK, et al. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics 2004;113 3 Pt 1:e221-4.
43. Danne T, Battelino T, Kordonouri O, Hanas R, Klinkert C, Ludvigsson J, et al. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. Pediatric Diabetes 2005;6:193-8.
44. Sullivan-Bolyai S, Knafl K, Tamborlane W, Grey M. Parent's reflections on managing their children's diabetes with insulin pumps. J Nursing Scholarsh 2004;36 4:316-23.
45. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. CSII: a "new" way to achieve strict metabolic control, decrease severe hypoglycemia and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22:1779-84.
46. Low KG, Massa L, Lehman D, Olshan JS. Insulin pump use in young adolescents with type 1 diabetes: a descriptive study. Pediatric Diabetes 2005;6 1:22-31.
47. Tamborlane WV, Fredrickson L. Insulin pump therapy of childhood diabetes: guidelines for us. Treat Endocrinol 2003;2:11-21.
48. Ahern JA, Ramchandani N, Cooper J, Himmel A, Silver D, Tamborlane WV. Using a primary nurse manager to implement DCCT recommendations in a large pediatric program. Diabetes Educ 2000;26 6:990-4.
49. Melzer SM, Richards GE, Covington ML. Reimbursement and costs of pediatric ambulatory diabetes care by using the resource-based relative value scale: is multidisciplinary care financially viable? Pediatric Diabetes 2004;5 3:133-42.
50. Boland E, Monsod T, Brandt CA, Fernando S, DeLucia M, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: Lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001;24:1858-62.
51. Diabetes Research in Children Network (DirecNet) Study Group. The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther 2003;5 5:781-9.
52. Diabetes Research in Children Network (DirecNet) Study Group. The accuracy of the Gluco Watch G2 biographer in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther 2003;5 5:791-800.
53. Diabetes Research in Children Network (DirecNet) Study Group. A multicenter study of the accuracy of the One Touch Ultra home glucose meter in children with type 1 diabetes. Diabetes Technol Ther 2003;5 6:933-41.
54. The DirecNet Study Group. Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes Technol Ther 2005;7 1:109-14.
55. DirecNet Study Group. Accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with T1DM. Diabetes 2006;55 Suppl 1:A91-2.
56. Weinzimer SA, Steil GM, Kurtz N, Swan KL, Tamborlane WV. Automated feedback-controlled insulin delivery in children with type 1 diabetes mellitus: a preliminary report. Diabetes 2006;55 Suppl 1:A102.